Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 3:16 PM
Ignite Modification Date:
2025-12-24 @ 3:16 PM
NCT ID:
NCT02070692
Eligibility Criteria:
Inclusion Criteria:
* Current user of the etonogestrel implant (Nexplanon, Implanon) for at least one month
* Experiencing bleeding episodes more frequently than every 24 days, or a single episode of bleeding lasting longer than 14 days
* English or Spanish speaking
* Planning to continue implant use for six months
* Access to a cell phone that can accept and send text messages
Exclusion Criteria:
* Postpartum within six months
* Post-abortion within six weeks
* Pregnant
* Breast-feeding
* Undiagnosed abnormal uterine bleeding pre-dating placement of contraceptive implant
* Bleeding dyscrasia
* Anticoagulation use
* Active cervicitis
* Allergy to tamoxifen
* History of venous thromboembolism
* Current or past breast or uterine malignancy
* Use of medication contraindicated with tamoxifen (coumadin, letrozole, bromocriptine, rifampicin, aminoglutethimide, phenobarbital)
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
15 Years
Maximum Age:
45 Years
Study:
NCT02070692
Study Brief:
Protocol Section:
NCT02070692